RASTRELLI, GIULIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.212
EU - Europa 3.175
AS - Asia 639
AF - Africa 8
SA - Sud America 7
OC - Oceania 1
Totale 11.042
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.196
PL - Polonia 984
IT - Italia 702
IE - Irlanda 596
SE - Svezia 380
HK - Hong Kong 314
CN - Cina 139
FI - Finlandia 99
RU - Federazione Russa 97
GB - Regno Unito 92
JO - Giordania 65
DE - Germania 53
CH - Svizzera 48
TR - Turchia 42
VN - Vietnam 34
ES - Italia 30
UA - Ucraina 23
IN - India 22
NL - Olanda 21
FR - Francia 16
CA - Canada 15
AT - Austria 11
SG - Singapore 8
RO - Romania 6
LT - Lituania 5
ID - Indonesia 4
PH - Filippine 4
ZA - Sudafrica 4
BR - Brasile 3
AR - Argentina 2
IR - Iran 2
PT - Portogallo 2
SC - Seychelles 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
AU - Australia 1
BE - Belgio 1
CL - Cile 1
CY - Cipro 1
CZ - Repubblica Ceca 1
EG - Egitto 1
GR - Grecia 1
HU - Ungheria 1
JP - Giappone 1
KR - Corea 1
MD - Moldavia 1
MK - Macedonia 1
MU - Mauritius 1
MX - Messico 1
PE - Perù 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
Totale 11.042
Salva come PNG Salva come JPEG
Città #
Fairfield 1.350
Warsaw 979
Ashburn 689
Woodbridge 612
Dublin 596
Seattle 567
Cambridge 546
Houston 511
Chandler 505
Wilmington 427
Lawrence 278
Altamura 276
Hong Kong 187
Princeton 186
Ann Arbor 159
Florence 133
Medford 100
Moscow 92
Beijing 87
Boston 85
San Diego 82
Boardman 59
Bern 48
Milan 48
Buffalo 47
New York 46
Jacksonville 45
Falls Church 39
Dong Ket 30
Hillsboro 30
Shanghai 30
Barcelona 28
Izmir 28
Norwalk 27
London 23
Rome 21
Dearborn 18
West Jordan 16
Redwood City 15
Andover 11
Pune 11
Toronto 11
Vienna 9
Bologna 8
Bremen 8
Chicago 8
Redmond 8
Barnet 7
Haarlem 7
Los Angeles 7
Marciano della Chiana 7
Hefei 6
Lappeenranta 6
Verona 6
Parma 5
Phoenix 5
Prescot 5
Tappahannock 5
Vilnius 5
Bari 4
Cagliari 4
Cape Town 4
Cerreto Guidi 4
Figline Valdarno 4
Islington 4
Laurel 4
Nanjing 4
Naples 4
Siena 4
Singapore 4
Southwark 4
Washington 4
Yreka 4
Ankara 3
Buting 3
Castelliri 3
Fremont 3
Giussano 3
Iseo 3
Istanbul 3
Kent 3
Medan 3
New Bedfont 3
Salerno 3
Voghera 3
Acerra 2
Acton 2
Ahvaz 2
Amsterdam 2
Arluno 2
Augusta 2
Bacoli 2
Blumenau 2
Bratislava 2
Campi Bisenzio 2
Cascina 2
Chennai 2
Città Della Pieve 2
Concord 2
Düsseldorf 2
Totale 9.312
Salva come PNG Salva come JPEG
Nome #
Treatment with human, recombinant FSH improves sperm DNA fragmentation in idiopathic infertile men depending on the FSH receptor polymorphism p.N680S: A pharmacogenetic study 246
Metabolic syndrome and lower urinary tract symptoms: the role of inflammation 222
FATTORI DI RISCHIO CONVENZIONALI E NON CONVENZIONALI NEL SOGGETTO CON DISFUNZIONE ERETTILE 217
Nonalcoholic steatohepatitis as a novel player in metabolic syndrome-induced erectile dysfunction: an experimental study in the rabbit. 207
Semen cryopreservation for men banking for oligospermia, cancers, and other pathologies: prediction of post-thaw outcome using basal semen quality. 205
Benign Prostatic Hyperplasia: A New Metabolic Disease of the Aging Male and Its Correlates with Sexual Dysfunctions 198
Efficacy and safety of avanafil 200 mg versus sildenafil 100 mg in the treatment of erectile dysfunction after robot-assisted unilateral nerve-sparing prostatectomy: A prospective multicentre study 132
Both comorbidity burden and low testosterone can explain symptoms and signs of testosterone deficiency in men consulting for sexual dysfunction 119
Insight on the intracrinology of menopause: androgen production within the human vagina 118
Physical activity counteracts metabolic syndrome-induced hypogonadotropic hypogonadism and erectile dysfunction in the rabbit. 115
Testosterone improves muscle fiber asset and exercise performance in a metabolic syndrome model. 114
The pharmacotherapy of male hypogonadism besides androgens 107
Testosterone therapy: a friend or a foe for the aging men with benign prostatic hyperplasia? 106
Testosterone Replacement Therapy and Cardiovascular Risk: A Review 100
Clinical characteristics of men complaining of premature ejaculation together with erectile dysfunction: a cross-sectional study. 98
Testosterone, cardiovascular disease and the metabolic syndrome. 98
Treatment of Functional Hypogonadism Besides Pharmacological Substitution 96
Associations between sex steroids and the development of metabolic syndrome: A longitudinal study in European men 95
Benign prostatic hyperplasia: a new metabolic disease? 94
Chromatin Protamination and Catsper Expression in Spermatozoa Predict Clinical Outcomes after Assisted Reproduction Programs 94
Anti-inflammatory effects of androgens in the human vagina 94
Erectile dysfunction in fit and healthy young men: psychological or pathological? 92
Body Mass Index Regulates Hypogonadism-Associated CV Risk:Results from a Cohort of Subjects with Erectile Dysfunction. 87
Cardiovascular impact of testosterone therapy for hypogonadism. 85
Treatment of premature ejaculation and comorbid endocrine and metabolic disorders 84
Natural history, risk factors and clinical features of primary hypogonadism in ageing men: Longitudinal Data from the European Male Ageing Study 83
The effect of statin therapy on testosterone levels in subjects consulting for erectile dysfunction. 82
Type 2 diabetes mellitus and testosterone: a meta-analysis study. 82
Endogenous Testosterone Levels and Cardiovascular Risk: Meta-Analysis of Observational Studies 82
Evaluation of cognitive subdomains, 25-hydroxyvitamin D, and 1,25-dihydroxyvitamin D in the European Male Ageing Study 82
Sexual function of the ageing male 81
Investigation on psychological symptoms improves ANDROTEST accuracy in predicting hypogonadism in subjects with sexual dysfunction. 81
How to define hypogonadism? Results from a population of men consulting for sexual dysfunction 81
Testosterone treatment and cardiovascular and venous thromboembolism risk: what is 'new'? 81
Endocrine control of ejaculation 81
Endocrine toxicity in cancer patients treated with nivolumab or pembrolizumab: results of a large multicentre study. 81
Testosterone and sexual function 80
Outcome of Medical and Psychosexual Interventions for Vaginismus: A Systematic Review and Meta-Analysis. 80
Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis 79
Gynecomastia in subjects with sexual dysfunction 78
Frequency of sexual activity and cardiovascular risk in subjects with erectile dysfunction: cross-sectional and longitudinal analyses. 78
SIEDY Scale 3, a New Instrument to Detect Psychological Component in Subjects with Erectile Dysfunction. 78
Serum PSA as a Predictor of Testosterone Deficiency. 77
An integrated approach with vardenafil orodispersible tablet and cognitive behavioral sex therapy for treatment of erectile dysfunction: a randomized controlled pilot study. 77
Dehydroepiandrosterone supplementation in elderly men: a meta-analysis study of placebo-controlled trials. 76
Fat boosts, while androgen receptor activation counteracts, BPH-associated prostate inflammation. 76
Obesity and Aging in Late-Onset Hypogonadism 76
The identification of prediabetes condition with ARIC algorithm predicts long-term CV events in patients with erectile dysfunction. 76
First-generation phosphodiesterase type 5 inhibitors dropout: A comprehensive review and meta-analysis 76
Pulse Pressure Independently Predicts Major Cardiovascular Events in Younger But Not in Older Subjects with Erectile Dysfunction. 75
Prolactin levels independently predict major cardiovascular events in patients with erectile dysfunction 75
Emerging medication for the treatment of male hypogonadism. 75
Testosterone and Metabolic Syndrome: A Meta-AnalysisStudy. 74
Impaired masturbation-induced erections: a new cardiovascular risk factor for male subjects with sexual dysfunction. 74
Clinical implications of measuring prolactin levels in males of infertile couples. 74
Lack of sexual privacy affects psychological and marital domains of male sexual dysfunction 74
Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis 73
Paediatric and adult-onset male hypogonadism 73
Clinical correlates of enlarged prostate size in subjects with sexual dysfunction. 73
Metabolic syndrome induces inflammation and impairs gonadotropin-releasing hormone neurons in the preoptic area of the hypothalamus in rabbits. 73
Meta-analysis of Results of Testosterone Therapy on Sexual Function Based on International Index of Erectile Function Scores. 73
Prevalence of endocrine and metabolic disorders in subjects with erectile dysfunction: a comparative study 72
Testosterone deficiency in the aging male and its relationship with sexual dysfunction and cardiovascular diseases 72
Effect of treatment with testosterone on endothelial function in hypogonadal men: a systematic review and meta-analysis 72
Sexual and Cardiovascular Correlates of Male Unfaithfulness. 71
Two unconventional risk factors for major adverse cardiovascular events in subjects with sexual dysfunction: low education and reported partner's hypoactive sexual desire in comparison with conventional risk factors. 70
The safety and efficacy of Avanafil, a new 2nd generation PDE5i: Comprehensive review and meta-analysis 70
Vascular and Chronological Age in Subjects with Erectile Dysfunction: A Cross-Sectional Study 70
SUBJECTIVE PERCEPTION OF EJACULATE VOLUME REFLECTS OBJECTIVE CHANGES IN EJACULATE VOLUME 70
Ipogonadismo maschile, sindrome metabolica e disfunzione erettile: dove comincia il bandolo della matassa. 70
Flaccid penile acceleration as a marker of cardiovascular risk in men without classical risk factors. 69
Pharmacological management of late-onset hypogonadism 69
Cardiovascular Risks of Androgen Deprivation Therapy for Prostate Cancer 69
Hypothyroidism and hyponatremia: data from a series of patients with iatrogenic acute hypothyroidism undergoing radioactive iodine therapy after total thyroidectomy for thyroid cancer 69
How to recognize late-onset hypogonadism in men with sexual dysfunction. 68
Clinical correlates of erectile dysfunction and premature ejaculation in men with couple infertility. 68
Characteristics of compensated hypogonadism in patients with sexual dysfunction 68
Glycemia but not the Metabolic Syndrome is Associated with Cognitive Decline: Findings from the European Male Ageing Study 68
Impact of Metabolically Healthy Obesity in Patients with Andrological Problems. 68
Poor response to alprostadil ICI test is associated with arteriogenic erectile dysfunction and higher risk of major adverse cardiovascular events. 68
Low Testosterone Levels Predict Clinical Adverse Outcomes in SARS-CoV-2 Pneumonia Patients 68
Testosterone and sexual function in men. 68
An update on heart disease risk associated with testosterone boosting medications. 67
Vascular and Chronological Age in Men With Erectile Dysfunction: A Longitudinal Study 67
Different medications for hypogonadotropic hypogonadism 66
Relationship of Testis Size and LH Levels with Incidence of Major Adverse Cardiovascular Events in Older Men with Sexual Dysfunction. 66
Diagnosis and treatment of late-onset hypogonadism: systematic review and meta-analysis of TRT outcomes. 66
Metformin in vitro and in vivo increases adenosine signaling in rabbit corpora cavernosa. 65
The hormonal control of ejaculation. 64
The Physician's Gender Influences the Results of the Diagnostic Workup for Erectile Dysfunction 64
Low prolactin is associated with sexual dysfunction and psychological or metabolic disturbances in middle-aged and elderly men: the European Male Aging Study (EMAS). 63
The role of prolactin in andrology: what is new? 62
Family History for Cardio-Metabolic Diseases: A Predictor of Major Adverse Cardiovascular Events in Men With Erectile Dysfunction 62
Predictors and clinical consequences of starting androgen therapy in men with low testosterone: results from the SIAMO-NOI registry 61
Development of and Recovery from Secondary Hypogonadism in Aging Men: Prospective Results from the EMAS 60
Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study. 59
High Triglycerides Predicts Arteriogenic Erectile Dysfunction and Major Adverse Cardiovascular Events in Subjects With Sexual Dysfunction 59
Testosterone Replacement Therapy for Sexual Symptoms 59
Low free testosterone is associated with hypogonadal signs and symptoms in men with normal total testosterone 58
Risk factors associated with primary and secondary reduced libido in male patients with sexual dysfunction 58
Totale 8.596
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.095
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.095
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019824 0 0 0 0 0 0 0 0 0 0 429 395
2019/20202.675 192 157 69 189 355 319 326 325 317 187 173 66
2020/20211.477 136 133 61 200 55 191 67 93 172 172 111 86
2021/20221.248 49 149 130 48 49 59 44 125 71 48 142 334
2022/20232.761 279 663 88 176 171 461 359 125 230 46 73 90
2023/20241.182 49 116 210 68 92 140 61 280 46 113 7 0
Totale 11.378